Exponent (NASDAQ:EXPO – Get Free Report) is set to release its earnings data after the market closes on Thursday, October 24th. Analysts expect Exponent to post earnings of $0.48 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
Exponent (NASDAQ:EXPO – Get Free Report) last posted its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.07. Exponent had a net margin of 19.35% and a return on equity of 28.39%. The firm had revenue of $132.43 million during the quarter, compared to the consensus estimate of $130.83 million. During the same quarter in the previous year, the firm posted $0.50 EPS. The business’s revenue for the quarter was up 2.1% compared to the same quarter last year. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Exponent Trading Down 2.5 %
Shares of EXPO opened at $110.05 on Tuesday. Exponent has a 12 month low of $64.61 and a 12 month high of $115.75. The firm’s 50 day moving average is $108.81 and its 200-day moving average is $99.40. The stock has a market capitalization of $5.58 billion, a PE ratio of 55.58 and a beta of 0.66.
Exponent Announces Dividend
Insider Transactions at Exponent
In other Exponent news, VP John Pye sold 3,956 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $105.00, for a total transaction of $415,380.00. Following the completion of the transaction, the vice president now directly owns 28,422 shares in the company, valued at $2,984,310. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.10% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Separately, Truist Financial reissued a “buy” rating and set a $120.00 target price (up from $100.00) on shares of Exponent in a report on Friday, July 26th.
Read Our Latest Report on EXPO
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
- Five stocks we like better than Exponent
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- Differences Between Momentum Investing and Long Term Investing
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- Health Care Stocks Explained: Why You Might Want to Invest
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.